Practice
Featured experience
Amazon.com $15 billion notes offering
We advised the underwriters on the offering
Circle $1.05 billion IPO
We are advising Circle on its IPO, the first IPO by a stablecoin issuer
Novartis $6 billion notes offering
We advised Novartis on the investment-grade debt offering
SailPoint $1.4 billion IPO
The shares are listed on the Nasdaq Global Select Market
Bristol Myers Squibb $7 billion notes offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with an SEC…
KWG Group Holdings $400 million high-yield notes offering
Davis Polk advised the initial purchasers in connection with a $400 million Regulation S high-yield offering by KWG Group…
Morgan Stanley $4.5 billion senior notes offering
Davis Polk advised Morgan Stanley in connection with its SEC-registered global offering of $4.5 billion aggregate principal…
Natural Order Acquisition $230 million IPO
Davis Polk advised the underwriters in connection with the $230 million initial public offering of 23,000,000 units of…
NatWest Group £1 billion contingent convertible additional Tier 1 capital notes
Davis Polk advised NatWest Group plc, a public limited company incorporated under the laws of Scotland, in connection with…
BioNTech $500 million SEC-registered at-the-market offering
Davis Polk advised the sales agents in connection with an SEC-registered at-the-market offering by BioNTech SE of its…
Fujian Yango $175 million high-yield notes offering
Davis Polk advised the joint lead managers in connection with the Regulation S offering of $175 million principal…
Affimed $75 million SEC-registered at-the-market offering program
Davis Polk advised the sales agent in connection with the establishment of an SEC-registered at-the-market offering…
Intercontinental Exchange $894.4 million block trade
Davis Polk advised the underwriter in connection with a block trade of 9,180,569 shares of common stock of…
RemeGen HK$4 billion Hong Kong IPO
Davis Polk advised the underwriters in the initial public offering of RemeGen Co., Ltd. on the Hong Kong Stock Exchange and…